These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1317222)

  • 21. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte macrophage colony stimulating factor (GM-CSF), the critical intermediate of inflammation-induced fetal membrane weakening, primarily exerts its weakening effect on the choriodecidua rather than the amnion.
    Sharma A; Kumar D; Moore RM; Deshmukh A; Mercer BM; Mansour JM; Moore JJ
    Placenta; 2020 Jan; 89():1-7. PubMed ID: 31665659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of peripartal collagenolysis in the human chorion-decidua.
    Bryant-Greenwood GD; Yamamoto SY
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):63-70. PubMed ID: 7847562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of dental pulp fibroblast matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression by interleukin-1alpha and tumor necrosis factor-alpha through a prostaglandin-dependent pathway.
    Lin SK; Wang CC; Huang S; Lee JJ; Chiang CP; Lan WH; Hong CY
    J Endod; 2001 Mar; 27(3):185-9. PubMed ID: 11487149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes.
    Li W; Challis JR
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6569-74. PubMed ID: 16174714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actinobacillus actinomycetemcomitans lipopolysaccharide regulates matrix metalloproteinase, tissue inhibitors of matrix metalloproteinase, and plasminogen activator production by human gingival fibroblasts: a potential role in connective tissue destruction.
    Bodet C; Andrian E; Tanabe S; Grenier D
    J Cell Physiol; 2007 Jul; 212(1):189-94. PubMed ID: 17299802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High levels of human chorionic gonadotropin retard first trimester trophoblast invasion in vitro by decreasing urokinase plasminogen activator and collagenase activities.
    Yagel S; Geva TE; Solomon H; Shimonovitz S; Reich R; Finci-Yeheskel Z; Mayer M; Milwidsky A
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1506-11. PubMed ID: 8263134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms.
    Zhang Y; McCluskey K; Fujii K; Wahl LM
    J Immunol; 1998 Sep; 161(6):3071-6. PubMed ID: 9743373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
    Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
    J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
    González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
    BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relaxin stimulates collagenase and plasminogen activator secretion by dispersed human amnion and chorion cells in vitro.
    Koay ES; Too CK; Greenwood FC; Bryant-Greenwood GD
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1332-4. PubMed ID: 6302128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human fetal membranes: a target tissue for relaxin.
    Koay ES; Bryant-Greenwood GD; Yamamoto SY; Greenwood FC
    J Clin Endocrinol Metab; 1986 Mar; 62(3):513-21. PubMed ID: 3003143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1.
    Sadowski T; Steinmeyer J
    Inflamm Res; 2001 Mar; 50(3):175-82. PubMed ID: 11339506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts.
    Ito A; Itoh Y; Sasaguri Y; Morimatsu M; Mori Y
    Arthritis Rheum; 1992 Oct; 35(10):1197-201. PubMed ID: 1418006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calmodulin differentially modulates the interleukin 1-induced biosynthesis of tissue inhibitor of metalloproteinases and matrix metalloproteinases in human uterine cervical fibroblasts.
    Ito A; Sato T; Ojima Y; Chen LC; Nagase H; Mori Y
    J Biol Chem; 1991 Jul; 266(21):13598-601. PubMed ID: 1649824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
    Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
    Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells.
    Niedbala MJ; Stein M
    Biomed Biochim Acta; 1991; 50(4-6):427-36. PubMed ID: 1801706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
    Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
    Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
    Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.